Literature DB >> 3014952

Release of superoxide anion by alveolar macrophages in pulmonary sarcoidosis.

C Aerts, B Wallaert, J M Grosbois, C Voisin.   

Abstract

Biological mechanisms involving nonprotease factors mediate the alterations of the alveolar structures which lead to the interstitial fibrosis of pulmonary sarcoidosis. Thus, we have investigated the production of oxidant species by BAL cells from 50 sarcoidosis patients and 18 healthy controls using a lucigenin-dependent CL method. Spontaneous and PMA-induced CL's were significantly higher in untreated patients and treated patients than in spontaneously cured patients or healthy controls (p less than .05). SOD inhibits 60 to 75% of spontaneous CL and 91 to 93% of PMA-induced CL. There was no apparent correlation between the CL of AM's and the radiological types, SACE levels, and gallium scans. In marked contrast, CL was significantly higher in patients with increased alveolar lymphocytosis (greater than or equal to 18%) than in patients with normal BAL. Since there were neither neutrophils nor eosinophils in BAL and since lymphocytes do not produce lucigenin-dependent CL, we believe that CL is produced by AM's. CL inhibition by SOD suggests that superoxide anion is involved in the production of CL. The release of both superoxide anion and related radicals may be of importance in the pathogenesis of pulmonary sarcoidosis.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3014952     DOI: 10.1111/j.1749-6632.1986.tb18495.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  9 in total

Review 1.  Immune aspects of sarcoidosis.

Authors:  L W Poulter
Journal:  Postgrad Med J       Date:  1988-07       Impact factor: 2.401

2.  Latent pulmonary involvement in Crohn's disease: biological, functional, bronchoalveolar lavage and scintigraphic studies.

Authors:  P Bonniere; B Wallaert; A Cortot; X Marchandise; Y Riou; A B Tonnel; J F Colombel; C Voisin; J C Paris
Journal:  Gut       Date:  1986-08       Impact factor: 23.059

3.  Generation of superoxide anion by alveolar macrophages in sarcoidosis: evidence for the activation of the oxygen metabolism in patients with high-intensity alveolitis.

Authors:  M A Cassatella; G Berton; C Agostini; R Zambello; L Trentin; A Cipriani; G Semenzato
Journal:  Immunology       Date:  1989-03       Impact factor: 7.397

4.  Immunopathology of ocular sarcoidosis.

Authors:  M R Angi; F Forattini; M Chilosi; A Cipriani; G De Caro; G Semenzato
Journal:  Int Ophthalmol       Date:  1990-01       Impact factor: 2.031

5.  Immunohistochemical analysis of sarcoid granulomas. Evaluation of Ki67+ and interleukin-1+ cells.

Authors:  M Chilosi; F Menestrina; P Capelli; L Montagna; M Lestani; G Pizzolo; A Cipriani; C Agostini; L Trentin; R Zambello
Journal:  Am J Pathol       Date:  1988-05       Impact factor: 4.307

6.  Activated alveolar macrophages in subclinical pulmonary inflammation in collagen vascular diseases.

Authors:  B Wallaert; F Bart; C Aerts; A Ouaissi; P Y Hatron; A B Tonnel; C Voisin
Journal:  Thorax       Date:  1988-01       Impact factor: 9.139

7.  Intercellular adhesion molecule 1 (ICAM-1) in the pathogenesis of mononuclear cell alveolitis in pulmonary sarcoidosis.

Authors:  K Dalhoff; S Bohnet; J Braun; B Kreft; K J Wiessmann
Journal:  Thorax       Date:  1993-11       Impact factor: 9.139

8.  In vivo imaging method to distinguish acute and chronic inflammation.

Authors:  Jen-Chieh Tseng; Andrew L Kung
Journal:  J Vis Exp       Date:  2013-08-16       Impact factor: 1.355

9.  Imbalance of pro- and anti-inflammatory cytokines in pulmonary sarcoidosis.

Authors:  J Müller-Quernheim
Journal:  Mediators Inflamm       Date:  1996       Impact factor: 4.711

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.